N-acetyltransferase-2 polymorphisms and schizophrenia

European Psychiatry

Volumn 21, Issue 5, 2006, Pages 333-337

  Saiz, Pilar Alejandra ^a   Garcia Portilla, Maria P ^a   Arango, Celso ^a   Morales, Blanca ^a   Alvarez, Victoria ^a   Coto, Eliecer ^a   Fernandez, Juan M ^a   Bousono, Manuel ^a   Bobes, Julio ^a  

^a UNIVERSIDAD DE OVIEDO   (Spain)

Author keywords

Genetic association; Genetic polymorphisms; N acetyltransferase 2; Schizophrenia

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; CONTROLLED STUDY; DNA EXTRACTION; DNA POLYMORPHISM; FEMALE; GENE; GENE SEQUENCE; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENOTYPE; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; N ACETYLTRANSFERASE 2 GENE; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; SCHIZOPHRENIA; SINGLE NUCLEOTIDE POLYMORPHISM; STATISTICAL ANALYSIS;

ADOLESCENT; ADULT; AGED; ARYLAMINE N-ACETYLTRANSFERASE; CHROMOSOME MAPPING; CHROMOSOMES, HUMAN, PAIR 8; FEMALE; FOUNDER EFFECT; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; MALE; MIDDLE AGED; POLYMORPHISM, GENETIC; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; POLYMORPHISM, SINGLE NUCLEOTIDE; SCHIZOPHRENIA;

EID: 33746004527     PISSN: 09249338     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.eurpsy.2005.12.002     Document Type: Article

References (45)

1. Ambrosone C.B., Freudenheim J.L., Graham S., Marshall J.R., Vena J.E., Brasure J.R., et al. Cigarette smoking, N-acetyltransferase 2 genetic polymorphisms, and breast cancer risk. JAMA 276 (1996) 1494-1501
2. Agundez J.A., Jimenez-Jimenez F.J., Luengo A., Molina J.A., Orti-Pareja M., Vazquez A., et al. Slow allotypic variants of the NAT2 gene and susceptibility to early-onset Parkinson's disease. Neurology 51 (1998) 1587-1592
3. Agundez J.A.G., Olivera M., Martinez C., Ladero J.M., and Benitez J. Identification and prevalence study of 17 allelic variants of the human NAT2 gene in a white population. Pharmacogenetics 6 (1996) 423-428
4. Blouin J.L., Dombroski B.A., Nath S.K., Lasseter V.K., Wolyniec P.S., Nestadt G., et al. Schizophrenia susceptibility loci on chromosomes 13q32 and 8p21. Nat. Genet. 20 (1998) 70-73
5. Brzustowicz L.M., Honer W.G., Chow E.W., Little D., Hogan J., Hodgkinson K., et al. Linkage of familial schizophrenia to chromosome 13q32. Am. J. Hum. Genet. 65 (1999) 1096-1103
6. Badner J.A., and Gershon E.S. Meta-analysis of whole-genome linkage scans of bipolar disorder and schizophrenia. Mol. Psychiatr. 7 (2002) 405-411
7. Blaveri E., Kalsi G., Lawrence J., Quested D., Moorey H., Lamb G., et al. Genetic association studies of schizophrenia using the 8p21-22 genes: prepronociceptin (PNOC), neuronal nicotinic cholinergic receptor alpha polypeptide 2 (CHRNA2) and arylamine N-acetyltransferase 1 (NAT1). Eur. J. Hum. Genet. 9 (2001) 469-472
8. Bandmann O., Vaughan J., Holmans P., Marsden C.D., and Wood N.W. Association of slow acetylator genotype for N-acetyltransferase 2 with familial Parkinson's disease. Lancet 350 (1997) 1136-1139
9. Butcher N.J., Boukouvala S., Sim E., and Minchin R.F. Pharmacogenetics of the arylamine N-acetyltransferases. Pharmacogenomics J. 2 (2002) 30-42
10. Blum M., Demierre A., Grant D.M., Heim M., and Meyer U.A. Molecular mechanism of slow acetylation of drugs and carcinogens in humans. Proc. Natl. Acad. Sci. USA 88 (1991) 5237-5241
11. Cascorbi I., Drakoulis N., Brockmoller J., Maurer A., Sperling K., and Roots I. Arylamine N-acetyltransferase (NAT2) mutations and their allelic linkage in unrelated Caucasian individuals: correlation with phenotypic activity. Am. J. Hum. Genet. 57 (1995) 581-592
12. Curtis D, Knight J. Genecounting Program. http://www.mds.qmul.ac.uk/statgen/dcurtis.html. 2003. Accessed, November 8, 2005.
13. Deutsch S.I., Rosse R.B., Schwartz B.L., and Mastropaolo J. A revised excitotoxic hypothesis of schizophrenia: therapeutic implications. Clin. Neuropharmacol. 24 (2001) 43-49
14. Dean K., and Murray R.M. Environmental risk factors for psychosis. Dialogues Clin. Neurosci. 7 (2005) 69-80
15. Drozdz M., Gierek T., Jendryczko A., Pilch J., and Piekarska J. N-acetyltransferase phenotype of patients with cancer of the larynx. Neoplasma 34 (1987) 481-484
16. De Leon J., and Diaz F.J. A meta-analysis of worldwide studies demonstrates an association between schizophrenia and tobacco smoking behaviours. Schizophr. Res. 76 (2005) 135-157
17. Gurling H.M.D., Kalsi G., Brynjolfson J., Sigmundsson T., Sherrington R., Mankoo B.S., et al. Genomewide genetic linkage analysis confirms the presence of susceptibility loci for schizophrenia, on chromosomes 1q32.2, 5q33.2, and 8p21-22 and provides support for linkage to schizophrenia, on chromosomes 11q23.3-24 and 20q12.1-11.23. Am. J. Hum. Genet. 68 (2001) 661-673
18. Garte S., Gaspari L., Alexandrie A.K., Ambrosone C., Autrup H., Autrup J.L., et al. Metabolic gene polymorphism frequencies in control populations. Cancer Epidemiol. Biomarkers Prev. 10 (2000) 1239-1248
19. González M.V., Alvarez V., Pello M.F., Menéndez M.J., Suárez C., and Coto E. Genetic polimorphism of N-acetyltransferase-2, glutathione S-transferase-M1, and cytochromes P450IIE1 and P450IID6 in the susceptibility to head and neck cancer. J. Clin. Pathol. 51 (1998) 294-298
20. Hovatta I., Varilo T., Suvisaari J., Terwilliger J.D., Ollikainen V., Arajärvi R., et al. A genomewide screen for schizophrenia genes in an isolated Finnish subpopulation, suggesting multiple susceptibility loci. Am. J. Hum. Genet. 65 (1999) 1114-1124
21. Hickman D., Risch A., Camilleri P., and Sim E. Genotyping human polymorphic arylamine N-acetyltransferase: identification of new slow allotypic variants. Pharmacogenetics 2 (1992) 217-226
22. Hein D.W., Doll M.A., Fretland A.J., Leff M.A., Webb S.J., Xiao G.H., et al. Molecular genetics and epidemiology of the NAT1 and NAT2 acetylation polymorphisms. Cancer Epidemiol. Biomarkers Prev. 9 (2000) 29-42
23. Hein D.W., Ferguson R.J., Doll M.A., Rustan T.D., and Gray K. Molecular genetics of human polymorphic N-acetyltransferase: enzymatic analysis of 15 recombinant wild-type, mutant, and chimeric NAT2 allozymes. Hum. Mol. Genet. 3 (1994) 729-734
24. Hirvonen A. Genetic factors in individual responses to environmental exposures. J. Occup. Environ. Med. 37 (1995) 37-43
25. Ilett K.F., David B.M., Detchon P., Castleden W.M., and Kwa R. Acetylation phenotype in colorectal carcinoma. Cancer Res. 47 (1987) 1466-1469
26. Kelly C., and McCreadie R.G. Smoking habits, current symptoms, and premorbid characteristics of schizophrenic patients in Nithsdale, Scotland. Am. J. Psychiatry 156 (1999) 1751-1757
27. Kaufmann C.A., Suarez B., Malaspina D., Pepple J., Svrakic D., Markel P.D., et al. NIMH Genetics Initiative Millenium Schizophrenia Consortium: linkage analysis of African-American pedigrees. Am. J. Med. Genet. 81 (1998) 282-289
28. Kendler K.S., MacLean C.J., O'Neill F.A., Burke J., Murphy B., Duke F., et al. Evidence for a schizophrenia vulnerability locus on chromosome 8p in the Irish Study of High-Density Schizophrenia Families. Am. J. Psychiatry 153 (1996) 1534-1540
29. Levinson D.F., Wildenauer D.B., Schwab S.G., Albus M., Hallmayer J., Lerer B., et al. Additional support for schizophrenia linkage on chromosomes 6 and 8: a multicenter study. Am. J. Med. Genet. 67 (1996) 580-594
30. Lewis C.M., Levinson D.F., Wise L.H., DeLisi L.E., Straub R.E., Hovatta I., et al. Genome scan metaanalysis of schizophrenia and bipolar disorder, part II: schizophrenia. Am. J. Hum. Genet. 73 (2003) 34-48
31. Lin H.J., Han C.Y., Lin B.K., and Hardy S. Slow acetylator mutations in the human polymorphic N-acetyltransferase gene in 786 Asians, Blacks, Hispanics, and Whites: application to metabolic epidemiology. Am. J. Hum. Genet. 52 (1993) 827-834
32. Lin H.J., Han C.Y., Lin B.K., and Hardy S. Ethnic distribution of slow acetilator mutations in the polymorphic N-acetyltransferase (NAT2) gene. Pharmacogenetics 4 (1994) 125-134
33. Matas N., Thygesen P., Stacey M., Rich A., and Sim E. Mapping AAC1, AAC2 and AACP, the genes for arylamine N-acetyltransferases, carcinogen metabolising enzymes on human chromosome 8p22, a region frequently deleted in tumours. Cytogenet. Cell Genet. 77 (1997) 290-295
34. O'Donovan M.C., and Owen M.J. Candidate-gene association studies of schizophrenia. Am. J. Hum. Genet. 65 (1999) 587-592
35. Pulver A.E., Lasseter V.K., Kasch L., Wolyniec P., Nestadt G., Blouin J.L., et al. Schizophrenia: a genome scan targets chromosomes 3p and 8p as potential sites of susceptibility genes. Am. J. Med. Genet. 60 (1995) 252-260
36. Perneger T.V. What's wrong with Bonferroni adjustements. BMJ (1998) 1236-1238
37. Rodrigo L., Alvarez V., Rodriguez M., Perez R., Alvarez R., and Coto E. N-acetyltransferase-2, glutathione S-transferase M1, alcohol dehydrogenase, and cytochrome P450IIE1 genotypes in alcoholic liver cirrhosis: a case-control study. Scand. J. Gastroenterol. 34 (1999) 303-307
38. Risch A., Wallace D.M., Bathers S., and Sim E. Slow N-acetylation genotype is a susceptibility factor in occupational and smoking related bladder cancer. Hum. Mol. Genet. 4 (1995) 231-236
39. Shaw S.H., Kelly M., Smith A.B., Shields G., Hopkins P.J., Loftus J., et al. A genome-wide search for schizophrenia susceptibility genes. Am. J. Med. Genet. 81 (1998) 364-376
40. Straub R.E., MacLean C.J., Ma Y., Webb B.T., Myakishev M.V., Harris-Kerr C., et al. Genome-wide scans of three independent sets of 90 Irish multiplex schizophrenia families and follow-up of selected regions in all families provides evidence for multiple susceptibility genes. Mol. Psychiatr. 7 (2002) 542-559
41. Smythies J. Endogenous neurotoxins relevant to schizophrenia. J. R. Soc. Med. 89 (1996) 679-680
42. Vatsis K.P., Martell K.J., and Weber W.W. Diverse point mutations in the human gene for polymorphic N-acetyltransferase. Proc. Natl. Acad. Sci. USA 88 (1991) 6333-6337
43. Von Schmiedeberg S., Fritsche E., Ronnau A.C., Specker C., Golka K., Richter-Hintz D., et al. Polymorphisms of the xenobiotic metabolizing enzymes CYP1A1 and NAT-2 in systemic sclerosis and lupus erythematosus. Adv. Exp. Med. Biol. 455 (1999) 147-152
44. Williams N.M., Rees M.I., Holmans P., Norton N., Cardno A.G., Jones L.A., et al. A two-stage genome scan for schizophrenia susceptibility genes in 196 affected sibling pairs. Hum. Mol. Genet. 8 (1999) 1729-1739
45. World Medical Association. Declaration of Helsinki. Recommendations guiding physicians in biomedical research involving human subjects. Amened by the 41st World Medical Assembly, Hong Kong, September, 1989.